Knowledge, Perception, and Application of Pharmacogenomics Among Hospital Pharmacists in Saudi Arabia

References

• Motulsky AG, Qi M. Pharmacogenetics, pharmacogenomics and ecogenetics. J Zhejiang Univ Sci B. 2006;7(2):169–170. doi:10.1631/jzus.2006.B016916421980
   PubMedGoogle Scholar
• Korngiebel DM, Thummel KE, Burke W. Implementing precision medicine: the ethical challenges. Trends Pharmacol Sci. 2017;38(1):8–14. doi:10.1016/j.tips.2016.11.00727939182
   PubMed Web of Science ®Google Scholar
• US National Library of Medicine. Genetics home reference, genomic research: what is pharmacogenomics?National Institute of Health, United States of America. Available from: https://ghr.nlm.nih.gov/primer/genomicresearch/pharmacogenomics. Accessed 7 23, 2020.
   Google Scholar
• Klein ME, Parvez MM, Shin JG. Clinical implementation of pharmacogenomics for personalized precision medicine: barriers and solutions. J Pharm Sci. 2017;106(9):2368–2379. doi:10.1016/j.xphs.2017.04.05128619604
   PubMed Web of Science ®Google Scholar
• Roden DM, McLeod HL, Relling MV, et al. Pharmacogenomics. Lancet. 2019;394(10197):521–532. doi:10.1016/S0140-6736(19)31276-031395440
   PubMed Web of Science ®Google Scholar
• Ehmann F, Caneva L, Prasad K, et al. Pharmacogenomic information in drug labels: European Medicines Agency perspective. Pharmacogenomics J. 2015;15(3):201–210. doi:10.1038/tpj.2014.8625707393
   PubMed Web of Science ®Google Scholar
• Peterson JF, Field JR, Shi Y, et al. Attitudes of clinicians following large-scale pharmacogenomics implementation. Pharmacogenomics J. 2016;16(4):393–398. doi:10.1038/tpj.2015.5726261062
   PubMed Web of Science ®Google Scholar
• Murphy JE, Green JS, Adams LA, Squire RB, Kuo GM, Mckay A. Pharmacogenomics in the curricula of colleges and schools of pharmacy in the United States. Am J Pharm Educ. 2010;74(1):7. doi:10.5688/aj74010720221358
   PubMed Web of Science ®Google Scholar
• Kuo GM, Ma JD, Lee KC, et al. Institutional profile: University of California San Diego Pharmacogenomics Education Program (PharmGenEdTM): bridging the gap between science and practice. Pharmacogenomics. 2011;12(2):149–153. doi:10.2217/pgs.10.21321332308
   PubMed Web of Science ®Google Scholar
• Lee KC, Hudmon KS, Ma JD, Kuo GM. Evaluation of a shared pharmacogenomics curriculum for pharmacy students. Pharmacogenomics. 2015;16(4):315–322. doi:10.2217/pgs.14.18125823780
   PubMed Web of Science ®Google Scholar
• McMahon T, Tucci J. The perceptions of pharmacists in Victoria, Australia on pharmacogenetics and its implications. Pharm Pract (Granada). 2011;9(3):141–147. doi:10.4321/S1886-3655201100030000524367468
   PubMedGoogle Scholar
• Muzoriana N, Gavi S, Nembaware V, Dhoro M, Matimba A. Knowledge, attitude, and perceptions of pharmacists and pharmacy students towards pharmacogenomics in Zimbabwe. Pharmacy. 2017;5(4):36. doi:10.3390/pharmacy5030036
   Google Scholar
• Yau A, Aziz ABA, Haque M. Knowledge, attitude and practice concerning pharmacogenomics among pharmacists: a systematic review. J Young Pharm. 2015;7(3):145–154. doi:10.5530/jyp.2015.3.3
   Google Scholar
• Tuteja S, Haynes K, Zayac C, Sprague JE, Bernhardt B, Pyeritz R. Community pharmacists’ attitudes towards clinical utility and ethical implications of pharmacogenetic testing. Per Med. 2013;10(8):793–800. doi:10.2217/pme.13.8524409195
   PubMed Web of Science ®Google Scholar
• Da P, Sl N, Bp S, Knowledge TSK. Awareness and attitude of pharmacists toward pharmacogenetic practice: perspective of community and hospital in Yogyakarta, Indonesia. J Community Med Health Educ. 2017;07(06):1–10. doi:10.4172/2161-0711.1000568
   Google Scholar
• Elewa H, Alkhiyami D, Alsahan D, Abdel-Aziz A. A survey on the awareness and attitude of pharmacists and doctors towards the application of pharmacogenomics and its challenges in Qatar. J Eval Clin Pract. 2015;21(4):703–709. doi:10.1111/jep.1237225929423
   PubMed Web of Science ®Google Scholar
• Owusu-Obeng A, Weitzel KW, Hatton RC, et al. Emerging roles for pharmacists in clinical implementation of pharmacogenomics. Pharmacotherapy. 2014;34(10):1102–1112. doi:10.1002/phar.148125220280
   PubMed Web of Science ®Google Scholar
• El-Ibiary SY, Cheng C, Alldredge B. Potential roles for pharmacists in pharmacogenetics. J Am Pharm Assoc. 2008;48(2):e21–e32. doi:10.1331/JAPhA.2008.07050
   Google Scholar
• Center for Arab Genomic Studies A division of Sheikh Hamdan award for medical sciences. Available from: http://cags.org.ae/. Accessed 7 25, 2020.
   Google Scholar
• CTGA. The Database for Genetic Disorders in Arabs. Accessed 7 25, 2020 Available from: http://www.cags.org.ae/ctgaguide3c2.pdf.
   Google Scholar
• Abu-Elmagd M, Assidi M, Schulten HJ, et al. Individualized medicine enabled by genomics in Saudi Arabia. BMC Genomics. 2015;8(1):24–27. doi:10.1186/1755-8794-8-S1-S3
   Web of Science ®Google Scholar
• Medicine MAAA-MEJ of F, 2004 undefined. Common genetics and metabolic diseases in Saudi Arabia. mejfm.com Accessed 7 25, 2020 Available from: http://www.mejfm.com/journal/Jul2004/CommonGenetics andMeta.pdf.
   Google Scholar
• Kirchheiner J, Roots I, Goldammer M, Rosenkranz B, Brockmöller J. Effect of genetic polymorphisms in cytochrome P450 (CYP) 2C9 and CYP2C8 on the pharmacokinetics of oral antidiabetic drugs: clinical relevance. Clin Pharmacokinet. 2005;44(12):1209–1225. doi:10.2165/00003088-200544120-0000216372821
   PubMed Web of Science ®Google Scholar
• Zhang X, Li L, Ding X, Kaminsky LS. Identification of cytochrome P450 oxidoreductase gene variants that are significantly associated with the interindividual variations in warfarin maintenance dose. Drug Metab Dispos. 2011;39(8):1433–1439. doi:10.1124/dmd.111.03883621562147
   PubMed Web of Science ®Google Scholar
• Saour JN, Shereen AW, Saour BJ, Mammo LA. CYP2C9 polymorphism studies in the Saudi population. Saudi Med J. 2011;32(4):347–352.21483991
   PubMed Web of Science ®Google Scholar
• Alzahrani A, Ragia G HH-B research, 2013 undefined. Genotyping of CYP2C9 and VKORC1 in the Arabic population of Al-Ahsa, Saudi Arabia. hindawi.com Available from: https://www.hindawi.com/journals/bmri/2013/315980/abs/. Accessed 8 3, 2020.
   Google Scholar
• Bizzari S, Qari A, Balobaid A, et al. Genetic Disorders in Saudi Arabia: A CTGA Perspective.
   Google Scholar
• Ministry of Health. Statistical Yearbook 2018. Kingdom of Saudi Arabia. Accessed 7 23, 2020 Available from: https://www.moh.gov.sa/en/Ministry/Statistics/book/Pages/default.aspx.
   Google Scholar
• MI El M, Al S, Al H, Qurachi MM, Al O. Consanguinity and major genetic disorders in Saudi children: a community-based cross-sectional study. Ann Saudi Med. 2008;28(3):169. doi:10.5144/0256-4947.2008.16918500181
   PubMed Web of Science ®Google Scholar
• Alejielat R, Ejielat Z, Andrawes S, Mhaidat NM. An evaluation of the knowledge, opinions, expectations and concerns toward pharmacogenomics among Jordanian pharmacists. Per Med. 2016;13(2):143–154. doi:10.2217/pme.15.5029749903
   PubMed Web of Science ®Google Scholar
• Just KS, Steffens M, Swen JJ, Patrinos GP, Guchelaar HJ, Stingl JC. Medical education in pharmacogenomics—results from a survey on pharmacogenetic knowledge in healthcare professionals within the European pharmacogenomics clinical implementation project Ubiquitous Pharmacogenomics (U-PGx). Eur J Clin Pharmacol. 2017;73(10):1247–1252. doi:10.1007/s00228-017-2292-528669097
   PubMed Web of Science ®Google Scholar
• Gurwitz D, Zika E, Hopkins MM. Pharmacogenetics in Europe: barriers and opportunities. Public Health Genomics. 2009;12(3). doi:10.1159/000189625
   Web of Science ®Google Scholar
• Mccullough KB, Formea CM, Berg KD, et al. Assessment of the pharmacogenomics educational needs of pharmacists. Am J Pharm Educ. 2011;75(3):3. doi:10.5688/ajpe7535121451755
   PubMed Web of Science ®Google Scholar
• Lay Kek T, Alam P. IMJM Pharmacogenomics based practice in Malaysia: the attitude, knowledge and adoption by the healthcare professionals. Int Med J Malaysia. 2014;13.
   Google Scholar
• Mills R, Haga SB. Clinical delivery of pharmacogenetic testing services: a proposed partnership between genetic counselors and pharmacists. Pharmacogenomics. 2013;14(8):957–968. doi:10.2217/pgs.13.7623746189
   PubMed Web of Science ®Google Scholar
• Williams MS. Genomic medicine implementation: learning by example. Am J Med Genet Part C Semin Med Genet. 2014;166(1):8–14. doi:10.1002/ajmg.c.31394
   Web of Science ®Google Scholar
• Albassam A, Alshammari S, Ouda G, Koshy S, Awad A. Knowledge, perceptions and confidence of physicians and pharmacists towards pharmacogenetics practice in Kuwait. PLoS One. 2018;13(9):e0203033. doi:10.1371/journal.pone.020303330183746
   PubMed Web of Science ®Google Scholar
• Lunenburg CATC, van der Wouden CH, Nijenhuis M, et al. Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction of DPYD and fluoropyrimidines. Eur J Hum Genet. 2020;28(4):508–517. doi:10.1038/s41431-019-0540-031745289
   PubMed Web of Science ®Google Scholar
• van der Wouden CH, Paasman E, Teichert M, Crone MR, Guchelaar H-J, Swen JJ. Assessing the implementation of pharmacogenomic panel-testing in primary care in the Netherlands utilizing a theoretical framework. J Clin Med. 2020;9(3):814. doi:10.3390/jcm9030814
   PubMed Web of Science ®Google Scholar
• First FDA-approved medicine manufactured using 3d printing technology now available spritam ® is designed to transform experience of taking epilepsy medication. Available from: https://www.aprecia.com/pdf/ApreciaSPRITAMLaunchPressRelease__FINAL.PDF. Accessed 224, 2018.
   Google Scholar
• Desta Z, Gammal RS, Gong L, et al. Clinical pharmacogenetics implementation consortium (CPIC) guideline for cyp2b6 and efavirenz-containing antiretroviral therapy. Clin Pharmacol Ther. 2019;106(4):726–733. doi:10.1002/cpt.147731006110
   PubMed Web of Science ®Google Scholar